Figure 6.
Meta-analysis of the incidence of neoplasia with the use of a GLP-1 receptor agonist versus placebo or other antidiabetic treatments, based on studies with a minimum duration of 3 years.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.